Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.

Item
http://www.wikidata.org/entity/Q38217708
Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice.The contribution of biotechnology toward progress in diagnosis, management, and treatment of allergic diseases.Emerging drugs for the treatment of perennial allergic rhinitis.Clinical use of adjuvants in allergen-immunotherapy.The future of immunotherapy for canine atopic dermatitis: a review.Adjuvants for allergy immunotherapeutics.Incorporation of tetanus-epitope into virus-like particles achieves vaccine responses even in older recipients in models of psoriasis, Alzheimer's and cat allergy.Efficacy of a therapeutic treatment using gas-filled microbubble-associated phospholipase A2 in a mouse model of honeybee venom allergy.Microbial Delivery Vehicles for Allergens and Allergen-Derived Peptides in Immunotherapy of Allergic Diseases.
P2860

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.

Item
http://www.wikidata.org/entity/Q38217708
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
@en
type
label
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
@en
prefLabel
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
@en
P2093
P2860
P304
P31
P356
10.1586/1744666X.2014.924854
P433
P478
P577
P698